INHIBITION OF OXIDATIVE DRUG-METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS IS RELATED TO THEIR LIPID SOLUBILITY

被引：48

作者：

DEACON, CS ^{[1
]}

LENNARD, MS ^{[1
]}

BAX, NDS ^{[1
]}

WOODS, HF ^{[1
]}

TUCKER, GT ^{[1
]}

机构：

[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT THERAPEUT,SHEFFIELD S10 2JF,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 12卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1981.tb01240.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：429 / 431

页数：3

共 18 条

[1]

BAX NDS, 1980, BRIT J CLIN PHARMACO, V10, P353

[2]

BAX NDS, 1980, 1ST WORLD C CLIN PHA

[3]

BAX NDS, BRIT J CLIN PHARMAC

[4] EFFECTS OF METOPROLOL AND PROPRANOLOL ON THEOPHYLLINE ELIMINATION [J].

CONRAD, KA ;

NYMAN, DW .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :463-467

[5]

FACINO RM, 1979, PHARMACOL RES COMMUN, V11, P433

[6] IMPAIRMENT OF ANTIPYRINE CLEARANCE IN HUMANS BY PROPRANOLOL [J].

GREENBLATT, DJ ;

FRANKE, K ;

HUFFMAN, DH .

CIRCULATION, 1978, 57 (06) :1161-1164

[7] IS THERE A RELATIONSHIP BETWEEN THE PHYSICAL-PROPERTIES AND CARDIOSELECTIVITY OF BETA-ADRENOCEPTOR ANTAGONISTS [J].

JACK, DB .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (04) :402-406

[8]

JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233

[9] LACK OF BIOLOGICAL INTERACTION OF ALPRENOLOL AND SALICYLATE IN MAN [J].

JOHNSSON, G ;

REGARDH, CG ;

SOLVELL, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) :9-14

[10]

KEENAGHAN J B, 1972, Journal of Pharmacology and Experimental Therapeutics, V180, P454

← 1 2 →